2019 annual financial data

Recursion Pharmaceuticals 2019 Net margin

Recursion Pharmaceuticals 2019 net margin with verified reported values.

Direct answer

Net margin was -3,654.3%.

Operating income was -62,441,000 USD and net income was -62,525,000 USD.
Operating cash flow was -57,042,000 USD.

Get free Recursion Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
1,711,000 USD
Operating income
-62,441,000 USD
Net income
-62,525,000 USD
Operating cash flow
-57,042,000 USD